Researcher
Emiel De Jaeghere
- Disciplines:Cancer diagnosis, Cancer prevention, Cancer epidemiology, Cancer therapy, Cancer biology, Oncology not elsewhere classified
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From16 Oct 2018 → Today - Department of Human Structure and Repair (Department)
Member
From1 Oct 2018 → 15 Oct 2018
Projects
1 - 1 of 1
- Targeting cancer-associated fibroblasts to overcome immunosuppressive mechanisms in mismatch repair-deficient tumorsFrom1 Oct 2018 → 30 Sep 2022Funding: FWO fellowships
Publications
1 - 10 of 26
- Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer : long-term follow-up and update on surgical outcome and oncologic results of a unique tertiary care single-center retrospective cohort(2023)
Authors: Axel Van Damme, Julie Rombaut, Amin Makar, Emiel De Jaeghere, Eline Naert, Hannelore Denys, Philippe Tummers, Katrien Vandecasteele
- A breath of relief : navigating the resolution of unexplained respiratory failure(2023)
Authors: Emiel De Jaeghere, Dieter Stevens, Eric Derom, Pieter Depuydt
Number of pages: 1 - Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study(2023)
Authors: Emiel De Jaeghere, Sandra Tuyaerts, An M. T. Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, et al.
Pages: 475 - 491 - 2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial(2022)Volume: 32
Authors: Emiel De Jaeghere, Sandra Tuyaerts, Ann M.T. van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, et al.
Pages: A187 - A188 - Risk of thrombo-embolic events in ovarian cancer : does bevacizumab tilt the scale? A systematic review and meta-analysis(2021)
Authors: Micky Saerens, Emiel De Jaeghere, Nele Vandemaele, Hannelore Denys, Eline Naert
- Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma(2021)Volume: 32
Authors: Emiel De Jaeghere, Sandra Tuyaerts, Ann M.T. Van Nuffel, An Hendrix, P. Vuylsteke, S. Henry, X.B. Trinh, P.A. Van Dam, S. Aspeslagh, A. De Caluwe, et al.
Pages: S1449 - S1450 - How are OCD patients and family members dealing with the waxing and waning pattern of the COVID-19 pandemic? Results of a longitudinal observational study(2021)
Authors: Hannelore Tandt, Inge Debruyckere, Lemke Leyman, Roos Colman, Emiel De Jaeghere, Hanna Van Parys, Chris Baeken, Christine Purdon
Pages: 1549 - 1563 - The nocebo effect and tobacco control : first, do no harm?(2020)
Authors: Emiel De Jaeghere, Gauthier Bouche, Piet Hoebeke, Pieter Holbrouck, Hannelore Denys
- Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer(2020)
Authors: Emiel De Jaeghere, Frederiek Laloo, Mieke Van Bockstal, Kathia De Man, Eline Naert, Philippe Tummers, Amin Makar, Pieter De Visschere, Frédéric Amant, Hannelore Denys
Pages: 335 - 343 - Tumor engineering a clinical relevant model that recapitulates the tumor environment of peritoneal metastases in vitro and in vivo(2019)
Authors: Elly De Vlieghere, Emiel De Jaeghere, Glenn Wagemans, Thibaut Van Acker, Christian Vanhove, Geert Berx, Frank Vanhaecke, Wim Ceelen, Bruno De Geest, Heidi Declercq, et al.
Number of pages: 1